QQQ   304.28 (+0.14%)
AAPL   122.94 (-0.11%)
MSFT   214.24 (-0.52%)
FB   281.85 (-1.97%)
GOOGL   1,821.84 (-0.17%)
AMZN   3,186.73 (-0.52%)
TSLA   593.38 (+4.32%)
NVDA   535.84 (-1.07%)
BABA   266.91 (+2.14%)
CGC   28.63 (+1.60%)
GE   10.60 (+1.63%)
MU   69.90 (+1.14%)
AMD   92.31 (-1.53%)
T   29.23 (+0.48%)
NIO   45.35 (-5.48%)
F   9.21 (+0.11%)
ACB   11.24 (+2.65%)
NFLX   497.52 (-1.16%)
BA   237.20 (+5.96%)
GILD   60.86 (-0.44%)
DIS   153.24 (-0.24%)
QQQ   304.28 (+0.14%)
AAPL   122.94 (-0.11%)
MSFT   214.24 (-0.52%)
FB   281.85 (-1.97%)
GOOGL   1,821.84 (-0.17%)
AMZN   3,186.73 (-0.52%)
TSLA   593.38 (+4.32%)
NVDA   535.84 (-1.07%)
BABA   266.91 (+2.14%)
CGC   28.63 (+1.60%)
GE   10.60 (+1.63%)
MU   69.90 (+1.14%)
AMD   92.31 (-1.53%)
T   29.23 (+0.48%)
NIO   45.35 (-5.48%)
F   9.21 (+0.11%)
ACB   11.24 (+2.65%)
NFLX   497.52 (-1.16%)
BA   237.20 (+5.96%)
GILD   60.86 (-0.44%)
DIS   153.24 (-0.24%)
QQQ   304.28 (+0.14%)
AAPL   122.94 (-0.11%)
MSFT   214.24 (-0.52%)
FB   281.85 (-1.97%)
GOOGL   1,821.84 (-0.17%)
AMZN   3,186.73 (-0.52%)
TSLA   593.38 (+4.32%)
NVDA   535.84 (-1.07%)
BABA   266.91 (+2.14%)
CGC   28.63 (+1.60%)
GE   10.60 (+1.63%)
MU   69.90 (+1.14%)
AMD   92.31 (-1.53%)
T   29.23 (+0.48%)
NIO   45.35 (-5.48%)
F   9.21 (+0.11%)
ACB   11.24 (+2.65%)
NFLX   497.52 (-1.16%)
BA   237.20 (+5.96%)
GILD   60.86 (-0.44%)
DIS   153.24 (-0.24%)
QQQ   304.28 (+0.14%)
AAPL   122.94 (-0.11%)
MSFT   214.24 (-0.52%)
FB   281.85 (-1.97%)
GOOGL   1,821.84 (-0.17%)
AMZN   3,186.73 (-0.52%)
TSLA   593.38 (+4.32%)
NVDA   535.84 (-1.07%)
BABA   266.91 (+2.14%)
CGC   28.63 (+1.60%)
GE   10.60 (+1.63%)
MU   69.90 (+1.14%)
AMD   92.31 (-1.53%)
T   29.23 (+0.48%)
NIO   45.35 (-5.48%)
F   9.21 (+0.11%)
ACB   11.24 (+2.65%)
NFLX   497.52 (-1.16%)
BA   237.20 (+5.96%)
GILD   60.86 (-0.44%)
DIS   153.24 (-0.24%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Gilead SciencesBiogenAmgenSeagenNovozymes A/S
SymbolNASDAQ:GILDNASDAQ:BIIBNASDAQ:AMGNNASDAQ:SGENOTCMKTS:NVZMY
Price Information
Current Price$60.86$244.09$226.91$180.16$55.27
52 Week RangeHoldHoldBuyBuySell
Beat the Market™ Rank
Overall Score2.92.22.51.40.9
Analysis Score4.14.13.32.30.0
Community Score3.33.03.02.51.8
Dividend Score3.30.02.50.01.7
Ownership Score1.72.51.71.70.0
Earnings & Valuation Score1.91.31.90.61.3
Analyst Ratings
Consensus RecommendationHoldHoldBuyBuySell
Consensus Price Target$76.15$306.13$254.08$176.75N/A
% Upside from Price Target25.13% upside25.42% upside11.97% upside-1.89% downsideN/A
Trade Information
Market Cap$76.29 billion$37.56 billion$132.10 billion$32.48 billion$16.42 billion
Beta0.530.520.761.130.57
Average Volume14,056,9681,740,7262,841,9021,111,38535,620
Sales & Book Value
Annual Revenue$22.45 billion$14.38 billion$23.36 billion$916.71 million$2.16 billion
Price / Sales3.402.615.6535.447.62
Cashflow$7.47 per share$39.24 per share$19.33 per shareN/A$1.42 per share
Price / Cash8.156.2211.74N/A38.94
Book Value$13.94 per share$69.82 per share$18.82 per share$10.95 per share$5.79 per share
Price / Book4.373.5012.0616.459.55
Profitability
Net Income$5.39 billion$5.89 billion$7.84 billion$-158,650,000.00$472.79 million
EPS$6.14$33.57$14.82($1.33)$1.65
Trailing P/E Ratio62.748.0818.30N/A35.20
Forward P/E Ratio8.919.6513.35N/A32.13
P/E Growth0.691.241.90N/AN/A
Net Margins5.48%35.63%29.42%-25.17%20.73%
Return on Equity (ROE)37.77%51.00%95.55%-18.32%27.20%
Return on Assets (ROA)12.76%23.54%15.52%-15.49%14.74%
Dividend
Annual Payout$2.72N/A$6.40N/A$0.52
Dividend Yield4.47%N/A2.82%N/A0.94%
Three-Year Dividend Growth36.96%N/A45.00%N/AN/A
Payout Ratio44.30%N/A43.18%N/A31.52%
Years of Consecutive Dividend Growth1 YearsN/A1 YearsN/AN/A
Debt
Debt-to-Equity Ratio1.65%0.69%3.12%N/A0.33%
Current Ratio3.25%2.06%2.28%4.71%1.43%
Quick Ratio3.15%1.79%1.88%4.39%0.88%
Ownership Information
Institutional Ownership Percentage75.20%78.92%71.72%91.96%0.11%
Insider Ownership Percentage0.13%0.54%0.36%31.10%N/A
Miscellaneous
Employees11,8007,40023,4001,6056,125
Shares Outstanding1.25 billion153.88 million582.17 million180.31 million297.00 million
Next Earnings Date2/2/2021 (Estimated)2/4/2021 (Estimated)2/4/2021 (Estimated)2/4/2021 (Estimated)12/9/2020 (Estimated)
OptionableOptionableOptionableOptionableOptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.